Windlas Biotech Limited (WINDLAS.NS)
INR 967.05
(8.38%)
INR 967.05
(8.38%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.29 Billion INR | 35.22% |
| 2022 | 478.7 Million INR | 18.85% |
| 2021 | 402.76 Million INR | -7.23% |
| 2020 | 434.14 Million INR | 34.78% |
| 2019 | 322.11 Million INR | 6.87% |
| 2018 | 301.39 Million INR | 34.11% |
| 2017 | 224.74 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 146.7 Million INR | -20.57% |
| 2023 FY | 647.28 Million INR | 35.22% |
| 2023 Q4 | 184.69 Million INR | -8.17% |
| 2023 Q1 | 139.54 Million INR | -8.23% |
| 2023 Q2 | 185.97 Million INR | 33.27% |
| 2023 Q3 | 201.12 Million INR | 8.15% |
| 2022 Q2 | 157.51 Million INR | 42.72% |
| 2022 FY | 478.7 Million INR | 18.85% |
| 2022 Q4 | 152.06 Million INR | 17.19% |
| 2022 Q3 | 129.76 Million INR | -17.62% |
| 2022 Q1 | 110.36 Million INR | 0.89% |
| 2021 Q3 | 98.97 Million INR | -1.82% |
| 2021 FY | 402.76 Million INR | -7.23% |
| 2021 Q4 | 109.39 Million INR | 10.53% |
| 2021 Q2 | 100.8 Million INR | 0.31% |
| 2021 Q1 | 100.49 Million INR | -2.23% |
| 2020 FY | 434.14 Million INR | 34.78% |
| 2020 Q3 | 150.28 Million INR | 55.36% |
| 2020 Q2 | 96.73 Million INR | -11.08% |
| 2020 Q4 | 102.78 Million INR | -31.61% |
| 2020 Q1 | 108.78 Million INR | 117.95% |
| 2019 FY | 322.11 Million INR | 6.87% |
| 2019 Q4 | 49.91 Million INR | 0.0% |
| 2018 FY | 301.39 Million INR | 34.11% |
| 2017 FY | 224.74 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 77.442% |
| Hester Biosciences Limited | 364.77 Million INR | -256.085% |
| Aarti Drugs Limited | 7.14 Billion INR | 81.83% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 58.477% |
| Albert David Limited | 1.33 Billion INR | 2.665% |
| Alembic Limited | 767.77 Million INR | -69.177% |
| Alkem Laboratories Limited | 19.46 Billion INR | 93.326% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -446.531% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -6188.197% |
| Brooks Laboratories Limited | -72.25 Million INR | 1897.722% |
| Eris Lifesciences Limited | 5.18 Billion INR | 74.933% |
| FDC Limited | 3.03 Billion INR | 57.185% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 85.534% |
| Gufic Biosciences Limited | 2.89 Billion INR | 55.115% |
| Hikal Limited | 1.49 Billion INR | 13.071% |
| Ind-Swift Limited | 1.22 Billion INR | -5.948% |
| Innova Captab Limited | 2.53 Billion INR | 48.73% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 73.718% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -506.845% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 74.968% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | 31.864% |
| Lupin Limited | 27.75 Billion INR | 95.321% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -4630.461% |
| Medico Remedies Limited | 277.11 Million INR | -368.714% |
| Morepen Laboratories Limited | 4.17 Billion INR | 68.88% |
| Nectar Lifesciences Limited | 3.89 Billion INR | 66.615% |
| Orchid Pharma Limited | 2.36 Billion INR | 44.987% |
| Procter & Gamble Health Limited | 2.78 Billion INR | 53.378% |
| RPG Life Sciences Limited | 2.29 Billion INR | 43.337% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -524.316% |
| Sigachi Industries Limited | 1.47 Billion INR | 11.874% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 133.712% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 71.81% |
| Themis Medicare Limited | 1.3 Billion INR | 0.323% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Vaishali Pharma Limited | 6.29 Million INR | -20536.956% |
| Wanbury Limited | 1.7 Billion INR | 23.917% |
| ZIM Laboratories Limited | 1.09 Billion INR | -18.284% |
| Ind-Swift Laboratories Limited | 2 Billion INR | 35.348% |
| Ipca Laboratories Limited | 29.59 Billion INR | 95.611% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 98.755% |
| Venus Remedies Limited | 534.65 Million INR | -142.942% |
| Sakar Healthcare Limited | 495.5 Million INR | -162.134% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 98.757% |
| Divi's Laboratories Limited | 18.31 Billion INR | 92.906% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | 70.967% |
| Mankind Pharma Limited | 40.86 Billion INR | 96.822% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Laurus Labs Limited | 3.94 Billion INR | 67.105% |
| Neuland Laboratories Limited | 5.31 Billion INR | 75.576% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 82.777% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 80.024% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 97.139% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -109.152% |
| Wockhardt Limited | 140 Million INR | -827.779% |
| Bal Pharma Limited | 214.56 Million INR | -505.348% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 98.082% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -5.515% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -135.481% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 82.023% |
| Shilpa Medicare Limited | 3.76 Billion INR | 65.469% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 19.67 Billion INR | 93.399% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -45783.781% |
| Granules India Limited | 6.52 Billion INR | 80.104% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -421.117% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 94.873% |
| NATCO Pharma Limited | 25.96 Billion INR | 94.997% |
| Suven Life Sciences Limited | -1.22 Billion INR | 205.961% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | 75.145% |
| Indoco Remedies Limited | 1.52 Billion INR | 14.793% |
| Alpa Laboratories Limited | 61.51 Million INR | -2011.501% |
| Lasa Supergenerics Limited | -458 Million INR | 383.597% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 131.564% |